Welcome to our dedicated page for HELIX ACQUISITION III SEC filings (Ticker: HLXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HELIX ACQUISITION III's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HELIX ACQUISITION III's regulatory disclosures and financial reporting.
Helix Acquisition Corp. III is a Cayman Islands blank check company formed in 2025 to complete an initial business combination, primarily targeting healthcare or healthcare-related industries. It has no operations and only nominal assets outside of cash.
On January 26, 2026, the company completed an IPO of 17,250,000 Class A ordinary shares at $10.00 per share, plus a private placement of 497,500 Class A shares to the sponsor at $10.00, and placed $172,500,000 into a U.S. trust account. Public shareholders can redeem their Class A shares for cash in connection with a business combination or certain charter amendments, subject to limitations, while the sponsor and insiders have waived redemption rights on their founder and private placement shares.
Helix has 24 months from the IPO closing to complete a business combination or redeem public shares and liquidate. It qualifies as an emerging growth company and a smaller reporting company, allowing reduced reporting and compliance requirements.
Helix Acquisition Corp. III received a Schedule 13G reporting that RA Capital Healthcare Fund, L.P. directly holds 1,250,000 Class A ordinary shares, equal to 7.0% of the class. This percentage is based on 17,747,500 Class A ordinary shares outstanding as of January 26, 2026.
RA Capital Management, L.P., and its managers Peter Kolchinsky and Rajeev Shah may be deemed beneficial owners for Section 13(d) purposes through their roles over the fund, but each disclaims beneficial ownership beyond reporting obligations. The filing is made on a passive basis, certifying the shares are not held to change or influence control of Helix Acquisition Corp. III.
Helix Acquisition Corp. III, a Cayman Islands-based blank check company, has completed its initial public offering of 17,250,000 Class A ordinary shares at $10.00 each, raising gross proceeds of $172,500,000. It also completed a private placement of 497,500 Class A shares to its sponsor at $10.00 per share for an additional $4,975,000.
A total of $172,500,000 from the IPO and private placement has been placed in a U.S.-based trust account for a future business combination, while cash outside the trust was $3,275,000 as of January 26, 2026. The balance sheet shows total assets of $175,779,938 and a shareholders’ deficit of $2,622,146, typical for a newly formed SPAC
The company has 24 months from the IPO closing to complete an initial business combination. Public shareholders will have the right to redeem their shares for cash held in the trust in connection with a business combination or if no deal is completed within the required timeframe.
Helix Holdings III LLC and Bihua Chen have filed a Schedule 13D showing significant sponsor control of Helix Acquisition Corp. III’s Class A ordinary shares. Helix Holdings III LLC reports beneficial ownership of 4,750,000 Class A ordinary shares (including Class B founder shares on an as-converted basis), representing 21.5% of the class. Bihua Chen, as managing member of the sponsor’s general partners and CEO and chair of the Issuer, is deemed to beneficially own 5,550,000 Class A ordinary shares, or 25.2%.
The filing details 4,252,500 founder Class B shares acquired for $25,000, 497,500 private placement Class A shares purchased for $4,975,000, and 800,000 Class A “Insider Public Shares” bought in the IPO for $8,000,000. A letter agreement and related contracts impose voting commitments in favor of a future business combination, extensive lock-up and redemption waivers, registration rights, an administrative services and indemnification arrangement, a $300,000 sponsor promissory note, and the potential for up to $1,500,000 of related-party loans convertible into post-combination private placement shares.
Helix Acquisition Corp. III’s Class A shares are the subject of a new ownership disclosure by Millennium-affiliated entities. Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report beneficial ownership of 1,098,535 Class A ordinary shares, representing 6.2% of the class, with shared voting and dispositive power.
Integrated Core Strategies (US) LLC separately reports beneficial ownership of 723,535 shares, or 4.1% of the class, also with shared voting and dispositive power. The filers state that the securities are not held for the purpose of changing or influencing control of Helix Acquisition Corp. III and are instead reported on a passive basis under Schedule 13G.